126 related articles for article (PubMed ID: 16362462)
1. Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats.
Nanke Y; Kotake S; Ninomiya T; Furuya T; Ozawa H; Kamatani N
Calcif Tissue Int; 2005 Dec; 77(6):376-85. PubMed ID: 16362462
[TBL] [Abstract][Full Text] [Related]
2. Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading.
Ichinose Y; Tanaka H; Inoue M; Mochizuki S; Tsuda E; Seino Y
Calcif Tissue Int; 2004 Oct; 75(4):338-43. PubMed ID: 15549649
[TBL] [Abstract][Full Text] [Related]
3. [Geranylgeranylacetone, an antiulcer drug, potently inhibits formation and function of human osteoclasts in vitro and bone loss in ovariectomized rats].
Nanke Y; Kotake S; Kamatani N
Nihon Rinsho; 2004 Feb; 62 Suppl 2():575-9. PubMed ID: 15035193
[No Abstract] [Full Text] [Related]
4. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of trabecular structure and bone volume by vitamin K(2) in mature rats with long-term tail suspension.
Iwasaki Y; Yamato H; Murayama H; Sato M; Takahashi T; Ezawa I; Kurokawa K; Fukagawa M
J Bone Miner Metab; 2002; 20(4):216-22. PubMed ID: 12115067
[TBL] [Abstract][Full Text] [Related]
6. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
Jin X; Zhu L; Li X; Jia J; Zhang Y; Sun X; Ma J; Liu Z; Ma X
Mol Med Rep; 2017 Feb; 15(2):890-898. PubMed ID: 28000877
[TBL] [Abstract][Full Text] [Related]
7. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.
Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A
Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124
[TBL] [Abstract][Full Text] [Related]
8. Novel Pyrazole Derivatives Effectively Inhibit Osteoclastogenesis, a Potential Target for Treating Osteoporosis.
Kuo TH; Lin TH; Yang RS; Kuo SC; Fu WM; Hung HY
J Med Chem; 2015 Jun; 58(12):4954-63. PubMed ID: 25996239
[TBL] [Abstract][Full Text] [Related]
9. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
10. Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats.
Beaudreuil J; Mbalaviele G; Cohen-Solal M; Morieux C; De Vernejoul MC; Orcel P
J Bone Miner Res; 1995 Jun; 10(6):971-7. PubMed ID: 7572322
[TBL] [Abstract][Full Text] [Related]
11. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
12. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
13. Theabrownin suppresses in vitro osteoclastogenesis and prevents bone loss in ovariectomized rats.
Liu T; Xiang Z; Chen F; Yin D; Huang Y; Xu J; Hu L; Xu H; Wang X; Sheng J
Biomed Pharmacother; 2018 Oct; 106():1339-1347. PubMed ID: 30119205
[TBL] [Abstract][Full Text] [Related]
14. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
[TBL] [Abstract][Full Text] [Related]
15. Histochemical evaluation for the biological effect of menatetrenone on metaphyseal trabeculae of ovariectomized rats.
Asawa Y; Amizuka N; Hara K; Kobayashi M; Aita M; Li M; Kenmotsu S; Oda K; Akiyama Y; Ozawa H
Bone; 2004 Oct; 35(4):870-80. PubMed ID: 15454094
[TBL] [Abstract][Full Text] [Related]
16. Disruption of NF-κB1 prevents bone loss caused by mechanical unloading.
Nakamura H; Aoki K; Masuda W; Alles N; Nagano K; Fukushima H; Osawa K; Yasuda H; Nakamura I; Mikuni-Takagaki Y; Ohya K; Maki K; Jimi E
J Bone Miner Res; 2013 Jun; 28(6):1457-67. PubMed ID: 23322687
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain.
Hara K; Akiyama Y; Nakamura T; Murota S; Morita I
Bone; 1995 Feb; 16(2):179-84. PubMed ID: 7756045
[TBL] [Abstract][Full Text] [Related]
18. Combination use of vitamin K(2) further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats.
Iwasaki Y; Yamato H; Murayama H; Sato M; Takahashi T; Ezawa I; Kurokawa K; Fukagawa M
J Bone Miner Metab; 2003; 21(3):154-60. PubMed ID: 12720049
[TBL] [Abstract][Full Text] [Related]
19. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of vitamin K2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study.
Akiyama Y; Hara K; Kobayashi M; Tomiuga T; Nakamura T
Jpn J Pharmacol; 1999 May; 80(1):67-74. PubMed ID: 10446758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
